• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MTY
Click for more information
3.57% 2.9¢

MEDICAL THERAPIES LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
MTYChange of name to Cellmid Limited18/11/09
MTYShareholders presentation17/11/09
MTYDistribution agreement signed with Yamasa CorporationPRICE SENSITIVE12/11/09
MTYAppendix 4C - monthlyPRICE SENSITIVE29/10/09
MTYLung cancer diagnostic license signed with CeleraPRICE SENSITIVE29/10/09
MTYChange of Director's Interest Notice23/10/09
MTYAnnual Report to shareholders22/10/09
MTYInitial Director's Interest Notice16/10/09
MTYNotice of Annual General Meeting/Proxy Form15/10/09
MTYAppointment of non-executive director12/10/09
MTYAgreement signed with Kumamoto UniversityPRICE SENSITIVE06/10/09
MTYMidkine test superior to conventional cancer markers08/09/09
MTYPreliminary Final ReportPRICE SENSITIVE31/08/09
MTYImportant European Patent GrantedPRICE SENSITIVE24/08/09
MTYShares released from escrow03/08/09
MTYCeasing to be a substantial holder31/07/09
MTYChange in substantial holding30/07/09
MTYAppendix 4C - quarterlyPRICE SENSITIVE30/07/09
MTYChange in substantial holding24/07/09
MTYChange in substantial holding22/07/09
MTYChange in substantial holding21/07/09
MTYChange in substantial holding21/07/09
MTYChange in substantial holding20/07/09
MTYAppendix 3B07/07/09
MTYMedical Therapies raised $550,000PRICE SENSITIVE07/07/09
MTYChange in substantial holding03/07/09
MTYTrading HaltPRICE SENSITIVE03/07/09
MTYAppendix 3B30/06/09
MTYChange of Director's Interest Notice29/06/09
MTYBecoming a substantial holder18/06/09
MTYChange in substantial holding26/05/09
MTYAppendix 3B15/05/09
MTYBecoming a substantial holder15/05/09
MTYChange in substantial holding15/05/09
MTYAnalyst Report and Interactive Roadshow Released15/05/09
MTYChange of Director's Interest Notice13/05/09
MTYAppendix 3B08/05/09
MTYResults of General Meeting05/05/09
MTYEGM Presentation05/05/09
MTYAppendix 4C - quarterlyPRICE SENSITIVE30/04/09
MTYChanges to capital raisingPRICE SENSITIVE21/04/09
MTY$700K Capital Raising CompletedPRICE SENSITIVE17/04/09
MTYNotice of General Meeting/Proxy Form02/04/09
MTYChange in substantial holding23/03/09
MTYChange in substantial holding18/03/09
MTYChange of Director's Interest Notice17/03/09
MTYAppendix 3B16/03/09
MTYNotice of initial substantial holder04/03/09
MTYAppendix 4D and Half Year AccountsPRICE SENSITIVE27/02/09
MTYHalf Year Accounts27/02/09
MTYAppendix 3B23/02/09
MTYCapital Raising Completed, Convertible Notes SatisfiedPRICE SENSITIVE23/02/09
MTYConvertible Notes ResolvedPRICE SENSITIVE18/02/09
MTYRemoval of $1.5M potential liabilityPRICE SENSITIVE09/02/09
MTYAppendix 4C - quarterlyPRICE SENSITIVE30/01/09
MTYAppendix 3B17/12/08
MTYShare Purchase Plan17/12/08
MTYChange of Director's Interest Notice16/12/08
MTYFunding UpdatePRICE SENSITIVE15/12/08
MTYChanges to Senior Management10/12/08
MTYMidkine Test Validated08/12/08
MTYLetter to Shareholders05/12/08
MTYAppendix 3B28/11/08
MTYAppendix 3B28/11/08
MTYResults of Meeting24/11/08
MTYChief Executive Officer's Address to Shareholders24/11/08
MTYChange of name to Cellmid Limited
18/11/09
MTYShareholders presentation
17/11/09
MTYDistribution agreement signed with Yamasa Corporation
12/11/09PRICE SENSITIVE
MTYAppendix 4C - monthly
29/10/09PRICE SENSITIVE
MTYLung cancer diagnostic license signed with Celera
29/10/09PRICE SENSITIVE
MTYChange of Director's Interest Notice
23/10/09
MTYAnnual Report to shareholders
22/10/09
MTYInitial Director's Interest Notice
16/10/09
MTYNotice of Annual General Meeting/Proxy Form
15/10/09
MTYAppointment of non-executive director
12/10/09
MTYAgreement signed with Kumamoto University
06/10/09PRICE SENSITIVE
MTYMidkine test superior to conventional cancer markers
08/09/09
MTYPreliminary Final Report
31/08/09PRICE SENSITIVE
MTYImportant European Patent Granted
24/08/09PRICE SENSITIVE
MTYShares released from escrow
03/08/09
MTYCeasing to be a substantial holder
31/07/09
MTYChange in substantial holding
30/07/09
MTYAppendix 4C - quarterly
30/07/09PRICE SENSITIVE
MTYChange in substantial holding
24/07/09
MTYChange in substantial holding
22/07/09
MTYChange in substantial holding
21/07/09
MTYChange in substantial holding
21/07/09
MTYChange in substantial holding
20/07/09
MTYAppendix 3B
07/07/09
MTYMedical Therapies raised $550,000
07/07/09PRICE SENSITIVE
MTYChange in substantial holding
03/07/09
MTYTrading Halt
03/07/09PRICE SENSITIVE
MTYAppendix 3B
30/06/09
MTYChange of Director's Interest Notice
29/06/09
MTYBecoming a substantial holder
18/06/09
MTYChange in substantial holding
26/05/09
MTYAppendix 3B
15/05/09
MTYBecoming a substantial holder
15/05/09
MTYChange in substantial holding
15/05/09
MTYAnalyst Report and Interactive Roadshow Released
15/05/09
MTYChange of Director's Interest Notice
13/05/09
MTYAppendix 3B
08/05/09
MTYResults of General Meeting
05/05/09
MTYEGM Presentation
05/05/09
MTYAppendix 4C - quarterly
30/04/09PRICE SENSITIVE
MTYChanges to capital raising
21/04/09PRICE SENSITIVE
MTY$700K Capital Raising Completed
17/04/09PRICE SENSITIVE
MTYNotice of General Meeting/Proxy Form
02/04/09
MTYChange in substantial holding
23/03/09
MTYChange in substantial holding
18/03/09
MTYChange of Director's Interest Notice
17/03/09
MTYAppendix 3B
16/03/09
MTYNotice of initial substantial holder
04/03/09
MTYAppendix 4D and Half Year Accounts
27/02/09PRICE SENSITIVE
MTYHalf Year Accounts
27/02/09
MTYAppendix 3B
23/02/09
MTYCapital Raising Completed, Convertible Notes Satisfied
23/02/09PRICE SENSITIVE
MTYConvertible Notes Resolved
18/02/09PRICE SENSITIVE
MTYRemoval of $1.5M potential liability
09/02/09PRICE SENSITIVE
MTYAppendix 4C - quarterly
30/01/09PRICE SENSITIVE
MTYAppendix 3B
17/12/08
MTYShare Purchase Plan
17/12/08
MTYChange of Director's Interest Notice
16/12/08
MTYFunding Update
15/12/08PRICE SENSITIVE
MTYChanges to Senior Management
10/12/08
MTYMidkine Test Validated
08/12/08
MTYLetter to Shareholders
05/12/08
MTYAppendix 3B
28/11/08
MTYAppendix 3B
28/11/08
MTYResults of Meeting
24/11/08
MTYChief Executive Officer's Address to Shareholders
24/11/08
refresh Created with Sketch. REFRESH
 

Top Stories

Cyclone signs MOU with Vale for development of Iron Bear play

Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.